Results 141 to 150 of about 56,190 (258)

Management of Cardiovascular Disorders in Patients with Noonan Syndrome: A Case Report

open access: yesJournal of Tehran University Heart Center, 2018
The Noonan syndrome is a rare disorder, one of whose major complications is cardiovascular involvement. A wide spectrum of congenital heart diseases has been observed in this syndrome.
Mohammad Rafie Khorgami   +3 more
doaj  

Long-term survival in patients with isolated pulmonary valve stenosis: a not so benign disease? [PDF]

open access: yesOpen Heart, 2021
Skoglund K   +4 more
europepmc   +1 more source

Effects of pulmonary balloon valvuloplasty on right coronary artery blood flow in pulmonary valve stenosis

open access: yes, 1998
Pulmonary balloon valvuloplasty results in improvement in the right coronary artery blood flow velocity pattern and the volumetric flow in patients with pulmonary valve stenosis.
Kallikazaros, IE   +4 more
core  

Differentiating the Clinical and Variant Spectrum of Hardikar Syndrome From Other MED12 ‐Related Developmental Disorders

open access: yesAmerican Journal of Medical Genetics Part A, Volume 200, Issue 7, Page 1619-1650, July 2026.
ABSTRACT The rare X‐linked female‐restricted Hardikar syndrome (HDKR, OMIM # 301068) is characterized by multiple congenital anomalies including orofacial clefts, gastrointestinal, genitourinary, and cardiac anomalies, but cognitive and neurobehavioral development is rarely impaired.
Tinne Warmoeskerken   +4 more
wiley   +1 more source

Muscular Fitness Components in Adults With Type 1 Diabetes: A Cross‐Sectional Study

open access: yesDiabetes/Metabolism Research and Reviews, Volume 42, Issue 5, July 2026.
ABSTRACT Aims We aimed to determine whether muscular fitness, focussing on power‐related components, is reduced in adults with type 1 diabetes (T1D) compared with the group without T1D. Methods Adults with T1D and healthy controls were enroled in the study.
Francesca Greco   +8 more
wiley   +1 more source

Sustainable Low‐Field Cardiovascular Magnetic Resonance in Changing Healthcare Systems—An Update

open access: yesNMR in Biomedicine, Volume 39, Issue 7, July 2026.
Low‐field cardiovascular MRI offers a cost‐effective and accessible alternative to conventional high‐field systems. Recent technological advances have improved image quality, safety, and device compatibility, expanding its clinical applications. These developments position low‐field CMR as a scalable solution to improve global cardiovascular imaging ...
Muhammad Umair   +9 more
wiley   +1 more source

Pulmonary hypertension and elevated transpulmonary gradient in patients with mitral stenosis.

open access: yes, 2010
BACKGROUND AND AIM OF THE STUDY: Pulmonary hypertension frequently complicates mitral stenosis, with a subset of these patients exhibiting pressures well in excess of their mitral valve hemodynamics.
Krasuski, Richard A   +5 more
core  

Homozygous Loss‐of‐Function Variant in SLC20A1 Coding for Ubiquitous Phosphate Transporter PiT1 Is Associated With Multiple Developmental Abnormalities

open access: yesClinical Genetics, Volume 110, Issue 1, Page 64-72, July 2026.
Biallelic SLC20A1 loss‐of‐function variant causes a previously unrecognized multisystem developmental disorder. We report the first homozygous case presenting with tetralogy of Fallot, renal agenesis, polydactyly, and growth impairment. Transcriptome analysis of patient‐derived fibroblasts suggests significant dysregulation of pathways critical for ...
Eugénie Koumakis   +9 more
wiley   +1 more source

A Nano‐Interception Strategy for Chronic Heart Failure: Prussian Blue Nanoparticles Disrupt Fibroblast‐Immune Communication via CCL2 Sequestration

open access: yesAdvanced Materials, Volume 38, Issue 31, 2 June 2026.
A nano‐interception strategy disrupts pathogenic fibroblast–macrophage crosstalk in chronic heart failure. Scalable Prussian blue nanoparticles selectively sequester CCL2 via ultrahigh‐affinity binding, preventing CCR2+ macrophage recruitment and breaking a key fibro‐inflammatory circuit. This approach demonstrates robust efficacy in murine and porcine
Bo Chen   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy